MktsMarkets

10x Genomics, Inc.
NASDAQ: TXGKey statistics
TXG News
Stories mentioning TXG from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 150,843 | 166,030 | 149,002 | 172,908 | 154,883 | 165,021 | 151,654 | 153,104 |
| Cost of Goods Sold | 44,665 | 52,985 | 48,695 | 47,824 | 49,438 | 54,066 | 45,261 | 48,884 |
| Gross Profit | 106,178 | 113,045 | 100,307 | 125,084 | 105,445 | 110,955 | 106,393 | 104,220 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 66,377 | 76,617 | 75,355 | 74,434 | 89,728 | 93,826 | 81,704 | 83,039 |
| Total Operating Expenses | 123,224 | 132,586 | 132,549 | 94,958 | 144,773 | 160,794 | 147,878 | 145,957 |
| Operating Income (Loss) | (17,046) | (19,541) | (32,242) | 30,126 | (39,328) | (49,839) | (41,485) | (41,737) |
| Interest Income | 5,014 | 6,892 | 5,199 | 4,271 | 3,686 | 4,508 | 4,971 | 4,715 |
| Interest Expense | ||||||||
| Other Expense | (815.00) | (2,544) | (1,165) | 2,603 | 2,136 | (3,049) | 2,078 | (56.00) |
| Pretax Income | (12,847) | (15,193) | (28,205) | 36,997 | (33,506) | (48,380) | (34,438) | (37,079) |
| Tax Provision | 623.00 | 1,059 | (733.00) | 2,459 | 852.00 | 648.00 | 1,315 | 818.00 |
| Net Income (Loss) | (13,470) | (16,252) | (27,472) | 34,538 | (34,358) | (49,028) | (35,753) | (37,897) |
| Earnings Per Share (Basic) | (0.10) | (0.13) | (0.22) | 0.28 | (0.28) | (0.41) | (0.30) | (0.32) |
| Earnings Per Share (Diluted) | (0.10) | (0.13) | (0.22) | 0.28 | (0.28) | (0.41) | (0.30) | (0.32) |
| Weighted Average Shares Outstanding (Basic) | 128,291 | 124,750 | 125,502 | 123,755 | 122,606 | 120,452 | 120,733 | 120,067 |
| Weighted Average Shares Outstanding (Diluted) | 128,291 | 124,750 | 125,502 | 124,510 | 122,606 | 120,452 | 120,733 | 120,067 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About TXG
10x Genomics, Inc. (NASDAQ: TXG) is a stock listed on the Nasdaq Stock Market under the ticker symbol TXG. It last traded at $51.80 (Nov 20, 2026, 9:30 AM ET), down 9.7% on the day. That gives 10x Genomics a market capitalisation of $7.2B.
Over the past 52 weeks TXG has traded between $15.18 and $102.81.
Revenue for the quarter ended Mar 31, 2026 was $150.8M; a net loss of $13.5M. Revenue was down 2.6% from $154.9M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $150.8M | -$13.5M | -8.9% |
| Dec 31, 2025 | $166.0M | -$16.3M | -9.8% |
| Sep 30, 2025 | $149.0M | -$27.5M | -18.4% |
| Jun 30, 2025 | $172.9M | $34.5M | 20.0% |
From 10x Genomics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…